These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29708760)

  • 1. A DNA-Based Nanocarrier for Efficient Gene Delivery and Combined Cancer Therapy.
    Liu J; Song L; Liu S; Jiang Q; Liu Q; Li N; Wang ZG; Ding B
    Nano Lett; 2018 Jun; 18(6):3328-3334. PubMed ID: 29708760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tailored DNA Nanoplatform for Synergistic RNAi-/Chemotherapy of Multidrug-Resistant Tumors.
    Liu J; Song L; Liu S; Zhao S; Jiang Q; Ding B
    Angew Chem Int Ed Engl; 2018 Nov; 57(47):15486-15490. PubMed ID: 30288887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors.
    Lu X; Wang QQ; Xu FJ; Tang GP; Yang WT
    Biomaterials; 2011 Jul; 32(21):4849-56. PubMed ID: 21458064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic gene and drug tumor therapy using a chimeric peptide.
    Han K; Chen S; Chen WH; Lei Q; Liu Y; Zhuo RX; Zhang XZ
    Biomaterials; 2013 Jun; 34(19):4680-9. PubMed ID: 23537665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance.
    Lu J; Zhao W; Liu H; Marquez R; Huang Y; Zhang Y; Li J; Xie W; Venkataramanan R; Xu L; Li S
    J Control Release; 2014 Dec; 196():272-86. PubMed ID: 25456831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
    Jia HZ; Zhang W; Zhu JY; Yang B; Chen S; Chen G; Zhao YF; Feng J; Zhang XZ
    J Control Release; 2015 Oct; 216():9-17. PubMed ID: 26272764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel.
    Zhang P; Wang C; Zhao J; Xiao A; Shen Q; Li L; Li J; Zhang J; Min Q; Chen J; Chen HY; Zhu JJ
    ACS Nano; 2016 Mar; 10(3):3637-47. PubMed ID: 26905935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor.
    Li Y; Zhai Y; Liu W; Zhang K; Liu J; Shi J; Zhang Z
    J Nanobiotechnology; 2019 Nov; 17(1):117. PubMed ID: 31783863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy.
    Song X; Zhang R; Liang C; Chen Q; Gong H; Liu Z
    Biomaterials; 2015 Jul; 57():84-92. PubMed ID: 25913253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of cationic MPEG-PCL-g-PEI micelles for co-delivery of Msurvivin T34A gene and doxorubicin.
    Shi S; Shi K; Tan L; Qu Y; Shen G; Chu B; Zhang S; Su X; Li X; Wei Y; Qian Z
    Biomaterials; 2014 May; 35(15):4536-47. PubMed ID: 24582554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel biodegradable HSAM nanoparticle for drug delivery.
    Liu B; Jiang S; Zhang W; Ye F; Wang YH; Wu J; Zhang DY
    Oncol Rep; 2006 Apr; 15(4):957-61. PubMed ID: 16525685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate/CaCO3 hybrid nanoparticles for efficient codelivery of antitumor gene and drug.
    Zhao D; Liu CJ; Zhuo RX; Cheng SX
    Mol Pharm; 2012 Oct; 9(10):2887-93. PubMed ID: 22894610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release.
    Ijäs H; Shen B; Heuer-Jungemann A; Keller A; Kostiainen MA; Liedl T; Ihalainen JA; Linko V
    Nucleic Acids Res; 2021 Apr; 49(6):3048-3062. PubMed ID: 33660776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.